Maridose Launches Innovative CRO Group for Cannabis-Based Drug Development
BRUNSWICK, Maine, Dec. 11, 2023 /PRNewswire/ -- Maridose, a leading DEA licensed manufacturer specializing in cannabis-based products, proudly announces the launch of their groundbreaking Contract Research Organization (CRO) group.
- BRUNSWICK, Maine, Dec. 11, 2023 /PRNewswire/ -- Maridose, a leading DEA licensed manufacturer specializing in cannabis-based products, proudly announces the launch of their groundbreaking Contract Research Organization (CRO) group.
- The company's innovative CRO services cater to pharmaceutical and biotech firms, academic institutions, authorized cannabis companies, and other entities legally permitted to conduct research on Schedule I drugs.
- Maridose's CRO services encompass a comprehensive suite of offerings designed to support every phase of drug development, from initial research to final commercialization.
- Maridose's CEO Lisa Rich-Milan expressed enthusiasm about this pivotal development, stating, "As the only DEA licensed manufacturer providing comprehensive CRO services, the launch of our CRO group marks a significant milestone for the research community.